Horizon Pharma Receives US Patent Allowance for DUEXIS(R) (Ibuprofen/Famotidine) - MarketWatch (press release) Print
MarketWatch (press release)
Long-term administration of NSAIDs, including ibuprofen, which is a component of DUEXIS tablets, has resulted in renal papillary necrosis and other renal injury. Use DUEXIS with caution in patients at risk (eg, the elderly; those with renal impairment,

...